The United Kingdom’s National Health Service on Tuesday announced what it described as a “life changing treatment” for sickle cell disease (SCD).
“Known as Crizanlizumab, the new drug will be delivered by a transfusion drip and works by binding to a protein in the blood cells to prevent the restriction of blood and oxygen supply that lead to a sickle cell crisis,” a statement from the NHS said.
The drug is expected to help persons living with SCD have “a much better quality of life.
SCD, according to the World Health Organisation (WHO), is a major genetic disease where the normal round shape of red blood cells becomes like crescent moons, leading to blood clots which can cause extreme pain in the back, chest, hands and feet.
There is no known cure yet, except stem cell transplants, a procedure which requires a donor, is expensive, emotionally exhausting and carries fatal risks.
The disease is prevalent in Nigeria, perhaps more than anywhere in the world.
About 30 percent of the population are carriers of the sickle cell trait. And almost three percent of Nigerians are living with SCD.
It is considered to be the most common genetic disorder in Nigeria, but testing is not available to the vast majority of infants, leading to thousands of deaths every year.
(AFP)
About the Author
474914 843122Id constantly want to be update on new content material on this site, bookmarked! 270329
65404 914259Outstanding read, I just passed this onto a friend who was performing some research on that. And he truly bought me lunch since I identified it for him smile So let me rephrase that: Thank you for lunch! 585983